FDA approves Lopid generic from Aurobindo

Dayton, N.J. — Aurobindo Pharma Limited announced Monday that it had received approval from the Food and Drug Administration for its generic of Pfizer’s Lopod (gemfibrozil) tablets in 600-mg dosage strength.

The drug is intended to treat high cholesterol alongside diet and exercise. Brand sales for Lopid in the U.S. were about $35.1 million for the twelve months ended July 2015, according to IMS Health.